Skip to main content

Cancer Immunotherapy

  • 1st Edition, Volume 90 - April 3, 2006
  • Latest edition
  • Authors: James Allison, Glen Dranoff
  • Language: English

For some time immunotherapy has been heralded as a breakthrough approach for cancer treatment. Although the potential of this strategy remains solid, the approach needs… Read more

World Book Day celebration

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Description

For some time immunotherapy has been heralded as a breakthrough approach for cancer treatment. Although the potential of this strategy remains solid, the approach needs considerable refinement. Whilst some programmes are looking to increase the understanding of molecular and cellular mechanisms underlying the stimulation of antitumor immunity, others are trying to find the most appropriate clinical setting that will reveal the role of the immune system in combating cancer. Among the most important discoveries have been tumor-specific antigens.

This thematic volume highlights some key issues and discusses where they may move forward. It has been put together by two leading cancer immunotherapists from two eminent institutions that focus on cancer research.

Readership

Immunologists, research oncologists, pathologists, and cell biologists

Table of contents

Engineered cellular vaccines
Blockade of T cell checkpoints.
Serex in the identification of target antigens
New approaches to tumor immunotherapy
Melanoma antigens
Antibodies and chimeric molecules
Tumor Immunosurveillance
Dendritic Cells
Strategies for Tumor Vaccination
DNA vaccines

Review quotes

PRAISE FOR THE SERIES:
"...among the most active volumes in the libraries of our universities and institutions."—SCIENCE

"A provocative and scholarly review of research." —JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Product details

  • Edition: 1
  • Latest edition
  • Volume: 90
  • Published: May 19, 2006
  • Language: English

About the authors

JA

James Allison

Affiliations and expertise
Howard Hughes Medical Institute Memorial Sloan-Kettering Cancer Center, New York, U.S.A.

GD

Glen Dranoff

Affiliations and expertise
Dana-Farber Cancer Institute, Boston, MA, U.S.A.

View book on ScienceDirect

Read Cancer Immunotherapy on ScienceDirect